A/Prof Thomas Loh

A/Prof Thomas Loh Head & Senior Consultant, Department of Otolaryngology - Head & Neck Surgery (ENT), National University Hospital Associate Professor, Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore MBBS (Singapore), FRCS (Gen Surg) (Glasg)

 A/Prof Loh is currently a Senior Consultant in Otolaryngology, with his practice mainly in Head and Neck Oncology. He sees mainly patients with head and neck cancers. His practice is in patients with cancers of the oral cavity, pharynx, larynx, thyroid and other sites. The majority of his cancer patients have nasopharyngeal carcinoma (NPC), the most common head and neck cancer in Singapore. He leads the Head and Neck Tumour Board, where radiation and medical oncologists together with surgical oncologists decide on the stage and the treatment for the cancer patients. A/Prof Loh performs surgery of the thyroid gland and parotid salivary gland and other major complicated surgery to treat cancers of the oral cavity, pharynx and larynx. Where it is suitable, he also treats cancer of the larynx using laser surgery. He also performs highly complicated tumours of the anterior skull base, or tumours at the junction just below the brain. A/Prof Loh is the Chief of Department and leads a large group of specialists as well as research staff in the Department. He also mentors a constant stream of elective students from overseas ranging from Australia to England, Netherlands and Germany just to name a few. He is a member of the Specialist Training Committee that oversees the Otolaryngology speciality in Singapore. He was awarded the Yong Yoo Lin School of Medicine Faculty Teaching Excellence Award and the NUS University Teaching Excellence Award in 2006 in recognition of his contribution to medical undergraduate teaching in NUS.

A/Prof Loh is also active in research. His main research is in the area of early diagnosis on NPC. He is the current Principle Investigator of 3 grants and a key collaborator in at least another 10 other concurrent studies. His research is focused on a screening programme for first-degree relatives of NPC patients. He was also the P.I for NUH site for a world- wide phase 3 study on a new cancer drug. A/Prof Loh has multiple collaborations with other Departments in the School of Medicine, NUS as well as other renowned institutions such as Division of Biomedical Sciences, Johns Hopkins Singapore.